PharmiWeb.com - Global Pharma News & Resources
29-Nov-2022

Synthetic Biology Market is anticipated to expand at a CAGR of 19.2% from 2023 to 2032 | insightSLICE

The global Synthetic Biology market size was estimated to be US$ 9.7 billion in 2021 and is expected grow at a CAGR of 19.2% between 2023 to 2032.

The Synthetic Biology Market Report will provide insights into Global Share, Developments, Statistics, and Forecasts, for the year 2022-2032. This study also takes into account the competitive environment and will give an outline of the top market participants in synthetic biology as well as their plans for the market.

Additionally, the report will also include statistics regarding important advancements, global and regional sales networks, business strategies, research and development initiatives, staff strength, and key executives for all significant market participants.

Access the sample report: https://www.insightslice.com/buy-now/343

Thermo Fisher Scientific Inc., for instance, recorded revenues of USD 25.5 billion in 2019, and the company’s sales report reveals that its Laboratory Products & Services business segment accounted for the majority of the sales earnings in 2019.

The key players of the Global Synthetic Biology Market are:

Algenol Biofuels, Inc., Agilent Technologies, Inc., Agrivida, Inc., ATG biosynthetic GmbH, Amyris, Inc., ATUM, Biosearch Technologies, Inc., Bayer AG, Bioneer Corporation, Bristol-Myers Squibb, Codexis, Inc., CBC Comprehensive Biomarker Center GmbH, Cyrus Biotechnology Inc., DuPont, Inc., Eurofins Genomics GmbH, GeneWorks Pty Ltd., GenScript Biotech Corporation, Evolva SA, Gene Script Corporation, Intrexon Corporation, Ginkgo Bioworks, Integrated DNA Technologies, Inc., Novozymes A/S, Synthego Corporation, Merck KGaA, New England Biolabs, Inc., Synthetic Genomics, Inc., Twist Bioscience, TeselaGen, and Thermo Fisher Scientific Inc.

Driving factors for the growth of Global Synthetic Biology Market

The term “synthetic biology” refers to the engineering of organisms to give them new traits and capacities for practical reasons. The Synthetic Biology market is increasingly used due to its adoption in producing synthetic living systems in the industry, and healthcare applications.

The creation of innovative medications with enhanced functions depends heavily on synthetic biology. The growth of the market for synthetic biology is mostly driven by increased expenditure on drug research.

The creation of enhanced enzymes for industrial applications and developments in tissue engineering is anticipated to support market expansion for synthetic biology worldwide.

During the projected period, concentrated research efforts for the creation of biologically modified microbes for environmental bioremediation are anticipated to support market expansion.

Read more about the report inclusions: https://www.insightslice.com/synthetic-biology-market

What is covered in our report?

With an emphasis on the business segment of various players, the research offers an in-depth assessment of leading companies with a major stake in the global market and therefore would identify the companies focused on synthetic biology products and technologies.

Additionally, the market shares of well-known businesses operating in the global synthetic biology market will be calculated. Thermo Fisher Scientific Inc., for example, conducts operations across four divisions called Life Sciences Solutions, Laboratory Products & Services, Specialty Diagnostics, and Analytical Instruments.

With a sales output of US$6.38 billion in 2019, the company’s Life Sciences Solutions sector provides synthetic biology products.

Every one of the Synthetic Biology companies along with their business strategies, product portfolios, important developments, SWOT analyses, and research and development priorities are taken into account in the study.

The parties involved in the market ecosystem and their contributions will be taken into account in the worldwide research of synthetic biology. All of the items under the company’s synthetic biology business sector would be the main emphasis of the product portfolio.

Similarly, the recent developments section from this report will concentrate on the most recent firm developments, such as regional expansion, mergers, and acquisitions, and also track the launch of new products, and strategic alliances in the global synthetic biology market.

Related reports:

Global Pulse Oximeters Market: https://www.insightslice.com/pulse-oximeters-market

Global Point of Care Molecular Diagnostics Market: https://www.insightslice.com/point-of-care-molecular-diagnostics-market

Regional performance of Synthetic Biology Market

As of 2019, North America accounted for the largest share of the global synthetic biology market.

This region is expected to continue to dominate during the forecast period as a result of rising investments in the creation of novel drugs and advanced therapeutics, progress in gene therapy, and the presence of top manufacturers and technology providers.

In the upcoming years, the synthetic biology market in North America is anticipated to be driven by the use of synthetic biology in the creation of artificial enzymes for use in food production and environmental applications.

Europe was a large contributor to the worldwide market for synthetic biology in 2019 and is predicted to expand significantly over the forecast period.

Due to rising investment in the development of the pharmaceutical and biotechnology industries as well as the improvement of the healthcare system, the Asia Pacific region is predicted to be the fastest growing and most profitable region for the synthetic biology products and services.

Global Synthetic Biology Market Key Segments:

Based on tools

  • Oligonucleotides & synthetic DNA
  • Enzymes
  • Cloning technologies kits
  • Synthetic cells
  • Chassis organisms
  • Xeno-nucleic acids

Based on technology

  • Gene synthesis
  • Genome engineering
  • Sequencing
  • Site-directed mutagenesis
  • Measurement & modeling
  • Microfluidics
  • Nanotechnology
  • Bioinformatics
  • Others

Based on applications

  • Pharmaceuticals
  • Drug discovery and therapeutics
  • Artificial tissue & tissue regeneration
  • Bfuel & renewable energy
  • Biomaterials & green chemicals
  • Synthetic food & beverage
  • Bioremediation
  • Bio-sensing
  • Others

By Geography:

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Proceed to purchase: https://www.insightslice.com/request-sample/343

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at info@insightslice.com.

Contact us:

Alex R

+1 707 736 6633

alex@insightslice.com

https://www.insightslice.com/

Linkedin | Twitter

Editor Details

Last Updated: 29-Nov-2022